{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:56:33Z","timestamp":1790704593715,"version":"4.1.0"},"reference-count":16,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-220","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:14:33Z","timestamp":1424736873000},"page":"245-248","source":"Crossref","is-referenced-by-count":51,"title":["Platelet-Derived Growth Factor Receptor-Tyrosine Kinase Inhibitor, Imatinib, Is Effective for Treating Pulmonary Hypertension Induced by Pulmonary Tumor Thrombotic Microangiopathy"],"prefix":"10.1536","volume":"56","author":[{"given":"Shun","family":"Minatsuki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Juntendo University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yao","sequence":"additional","affiliation":[{"name":"Division for Health Service Promotion, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Muraoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Inaba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"Maki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Juntendo University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fukayama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sakashita N, Yokose C, Fujii K, Matsumoto M, Ohnishi K, Takeya M. Pulmonary tumor thrombotic microangiopathy resulting from metastatic signet ring cell carcinoma of the stomach. Pathol Int 2007; 57: 383-7.","DOI":"10.1111\/j.1440-1827.2007.02111.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990; 66: 587-92.","DOI":"10.1002\/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yokomine T, Hirakawa H, Ozawa E, Shibata K, Nakayama T. Pulmonary thrombotic microangiopathy caused by gastric carcinoma. J Clin Pathol 2010; 63: 367-9.","DOI":"10.1136\/jcp.2010.075739"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Abe H, Hino R, Fukayama M. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer. Virchows Arch 2013; 462: 523-31.","DOI":"10.1007\/s00428-013-1403-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Miyano S, Izumi S, Takeda Y, <i>et al<\/i>. Pulmonary tumor thrombotic microangiopathy. J Clin Oncol 2007; 25: 597-9.","DOI":"10.1200\/JCO.2006.09.0670"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chinen K, Kazumoto T, Ohkura Y, Matsubara O, Tsuchiya E. Pulmonary tumor thrombotic microangiopathy caused by a gastric carcinoma expressing vascular endothelial growth factor and tissue factor. Pathol Int 2005; 55: 27-31.","DOI":"10.1111\/j.1440-1827.2005.01783.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takahashi F, Kumasaka T, Nagaoka T, <i>et al<\/i>. Osteopontin expression in pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma. Pathol Int 2009; 59: 752-6.","DOI":"10.1111\/j.1440-1827.2009.02439.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hibbert M, Braude S. Tumour microembolism presenting as \u201cprimary pulmonary hypertension\u201d. Thorax 1997; 52: 1016-7.","DOI":"10.1136\/thx.52.11.1016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hosoya Y, Watanabe M, Terashima M, <i>et al<\/i>. Cardiac magnetic resonance imaging in a patient with amniotic fluid embolism associated with severe cardiopulmonary complications. Int Heart J 2013; 54: 119-22.","DOI":"10.1536\/ihj.54.119"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hara T, Yamaguchi K, Iwase T, <i>et al<\/i>. Eosinophilic myocarditis due to chung-strauss syndrome with markedly elevated eosinophil cationic protein. Int Heart J 2013; 54: 51-3.","DOI":"10.1536\/ihj.54.51"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Katano M, Nakamura M, Fujimoto K, Miyazaki K, Morisaki T. Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Ann Surg 1998; 227: 365-71.","DOI":"10.1097\/00000658-199803000-00008"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yoshida K, Yasui W, Ito H, Tahara E. Growth factors in progression of human esophageal and gastric carcinomas. Exp Pathol 1990; 40: 291-300. (Review)","DOI":"10.1016\/S0232-1513(11)80316-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wang X, Louden C, Ohlstein EH, Stadel JM, Gu JL, Yue TL. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler Thromb Vasc Biol 1996; 16: 1365-72.","DOI":"10.1161\/01.ATV.16.11.1365"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ogawa A, Yamadori I, Matsubara O, Matsubara H. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med 2013; 52: 1927-30.","DOI":"10.2169\/internalmedicine.52.0718"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hoeper MM, Barst RJ, Bourge RC, <i>et al<\/i>. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation 2013; 127: 1128-38.","DOI":"10.1161\/CIRCULATIONAHA.112.000765"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hatano M, Yao A, Shiga T, Kinugawa K, Hirata Y, Nagai R. Imatinib mesylate has the potential to exert its efficacy by down-regulating the plasma concentration of platelet-derived growth factor in patients with pulmonary arterial hypertension. Int Heart J 2010; 51: 272-6.","DOI":"10.1536\/ihj.51.272"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:06:25Z","timestamp":1498197985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/2\/56_14-220\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-220","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}